Adaptive Biotechnologies Corporation
ADPT
$16.37
$0.251.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -242.06% | 137.43% | 14.20% | 11.19% | -4.56% |
| Total Depreciation and Amortization | -4.77% | -2.15% | -4.84% | 6.36% | -3.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.29% | -8.86% | 9.44% | -6.18% | 0.75% |
| Change in Net Operating Assets | 92.76% | -538.42% | 67.14% | -628.76% | 123.44% |
| Cash from Operations | 128.83% | 42.66% | 56.36% | -128.04% | 53.85% |
| Capital Expenditure | -55.50% | 37.56% | 47.97% | -1,473.75% | 76.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -143.05% | 342.19% | -85.09% | 20.87% | 294.23% |
| Cash from Investing | -147.75% | 416.53% | -86.92% | 15.62% | 318.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,186.10% | 4.60% | -70.46% | 4,192.13% | 217.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,186.10% | 4.60% | -70.46% | 4,192.13% | 217.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.58% | 258.42% | -394.25% | -73.96% | 144.88% |